Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/12123
Title: Incidence of cerebral microbleeds in preclinical Alzheimer disease.
Authors: Yates, Paul A;Desmond, Patricia M;Phal, Pramit M;Steward, Christopher;Szoeke, Cassandra;Salvado, Olivier;Ellis, Kathryn A;Martins, Ralph N;Masters, Colin L;Ames, David;Villemagne, Victor L;Rowe, Christopher C
Institutional Author: AIBL Research Group
Affiliation: From the Department of Nuclear Medicine and Centre for PET (P.A.Y., V.L.V., C.C.R.), Austin Health, Heidelberg; The University of Melbourne (P.A.Y., P.M.D., C.S., C.C.R.), Parkville; Department of Radiology (P.M.D., P.M.P., C.S.), Royal Melbourne Hospital, Parkville; National Ageing Research Institute (D.A.), Parkville; CSIRO Preventative Health Flagship (O.S.), Parkville; Florey Institute of Neuroscience and Mental Health (K.A.E., C.L.M., V.L.V.), The University of Melbourne, Parkville; Academic Unit for Psychiatry of Old Age (K.A.E., D.A.), Department of Psychiatry, The University of Melbourne, Kew, Victoria; Centre of Excellence for Alzheimer's Disease Research and Care (R.N.M.), School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Australia
Issue Date: 12-Mar-2014
Citation: Neurology 2014; 82(14): 1266-73
Abstract: We sought to determine the incidence and associations of lobar microbleeds (LMBs) in a longitudinal cohort with (11)C-Pittsburgh compound B (PiB) PET imaging.One hundred seventy-four participants from the observational Australian Imaging, Biomarkers and Lifestyle Study of Ageing (97 with normal cognition [NC], 37 with mild cognitive impairment [MCI], and 40 with Alzheimer disease [AD] dementia) were assessed at 3 time points over 3 years with 3-tesla susceptibility-weighted MRI and (11)C-PiB PET. MRIs were inspected for microbleeds, siderosis, infarction, and white matter hyperintensity severity, blind to clinical and PiB findings. Neocortical PiB standardized uptake value ratio, normalized to cerebellar cortex, was dichotomized as positive or negative (PiB+/-, standardized uptake value ratio >1.5). Annualized LMB incidence was calculated, and logistic regression was used to determine the association of incident LMBs with PiB, APOE ε4+ status, and cerebrovascular disease.LMBs were present in 18.6% of NC, 24.3% of MCI, and 40% of AD participants (p < 0.05 vs NC). LMB incidence was 0.2 ± 0.6 per year in NC participants, 0.2 ± 0.5 in MCI, and 0.7 ± 1.4 in AD (p < 0.03 vs NC) and was 6-fold higher in PiB+ than PiB-NC. Incident LMBs were associated with age, APOE ε4+, PiB+, and baseline LMBs. Incidence of multiple LMBs was also associated with lacunar infarction and white matter hyperintensity severity.Older age, baseline LMBs, higher β-amyloid burden, and concomitant cerebrovascular disease may all confer higher risk of incident LMBs. This should be considered when designing protocols for amyloid-modifying clinical trials.
Internal ID Number: 24623839
URI: http://ahro.austin.org.au/austinjspui/handle/1/12123
DOI: 10.1212/WNL.0000000000000285
URL: http://www.ncbi.nlm.nih.gov/pubmed/24623839
Type: Journal Article
Subjects: Adult
Aged
Aged, 80 and over
Alzheimer Disease.complications.radionuclide imaging
Amyloid.metabolism
Aniline Compounds.diagnostic use
Australia
Brain.pathology.radionuclide imaging
Cerebral Small Vessel Diseases.complications.diagnosis
Female
Humans
Incidence
Intracranial Hemorrhages.complications.epidemiology.radionuclide imaging
Magnetic Resonance Imaging.methods
Male
Middle Aged
Positron-Emission Tomography.methods
Thiazoles.diagnostic use
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.